Abstract:The superfamily of G protein-coupled receptors (GPCRs) contains immense structural and functional diversity and mediates a myriad of biological processes upon activation by various extracellular signals. Critical roles of GPCRs have been established in bone development, remodeling, and disease. Multiple human GPCR mutations impair bone development or metabolism, resulting in osteopathologies. Here we summarize the disease phenotypes and dysfunctions caused by GPCR gene mutations in humans as well as by deletion in animals. To date, 92 receptors (5 glutamate family, 67 rhodopsin family, 5 adhesion, 4 frizzled/taste2 family, 5 secretin family, and 6 other 7TM receptors) have been associated with bone diseases and dysfunctions (36 in humans and 72 in animals). By analyzing data from these 92 GPCRs, we found that mutation or deletion of different individual GPCRs could induce similar bone diseases or dysfunctions, and the same individual GPCR mutation or deletion could induce different bone diseases or dysfunctions in different populations or animal models. Data from human diseases or dysfunctions identified 19 genes whose mutation was associated with human BMD: 9 genes each for human height and osteoporosis; 4 genes each for human osteoarthritis (OA) and fracture risk; and 2 genes each for adolescent idiopathic scoliosis (AIS), periodontitis, osteosarcoma growth, and tooth development. Reports from gene knockout animals found 40 GPCRs whose deficiency reduced bone mass, while deficiency of 22 GPCRs increased bone mass and BMD; deficiency of 8 GPCRs reduced body length, while 5 mice had reduced femur size upon GPCR deletion. Furthermore, deficiency in 6 GPCRs induced osteoporosis; 4 induced osteoarthritis; 3 delayed fracture healing; 3 reduced arthritis severity; and reduced bone strength, increased bone strength, and increased cortical thickness were each observed in 2 GPCR-deficiency models. The ever-expanding number of GPCR mutation-associated diseases warrants accelerated molecular analysis, population studies, and investigation of phenotype correlation with SNPs to elucidate GPCR function in human diseases.

The Distinct Role of the Extra-Large G Protein alpha-Subunit XL alpha s

The Distinct Role of the Extra-Large G Protein ɑ-Subunit XLɑs

GNAS Gene Mutations Affecting XLαs and Bone Health: A Long Neglected Relationship.

GNAS gene mutations affecting <i>XLas</i> and bone health: A long neglected relationship

A novel nonsense mutation c.424G>T (p. G142X) in the first exon of XLas leading to osteopetrosis

Author Response for "A Paternally Inherited Nonsense Variant C.424g > T (p.g142*) in the First Exon of XLαs in an Adult Patient with Hypophosphatemia and Osteopetrosis"

[Pseudohypoparathyroidism and GNAS Gene Defects: Clinical Evaluation and Molecular Analysis in 20 Children].

Alternative Gnas gene products have opposite effects on glucose and lipid metabolism.

Paternally inherited gsα mutation impairs adipogenesis and potentiates a lean phenotype in vivo.

Mutant <i>B3GALT6</i> in a Multiplex Family: A Dominant Variant Co-Segregated With Moderate Malformations

Molecular Cloning and Expression Analysis of the GNAS Gene in Pig and Porcine Fibroblast Cells.

Increased insulin sensitivity in paternal Gnas knockout mice is associated with increased lipid clearance

The role of GPCRs in bone diseases and dysfunctions

A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report

Disease-causing Mutation in GPR54 Reveals the Importance of the Second Intracellular Loop for Class A G-protein-coupled Receptor Function

Effect of Glycine Substitutions on Α5(iv) Chain Structure and Structure–phenotype Correlations in Alport Syndrome

Identification of a novel GNAS mutation for pseudohypoparathyroidism in a Chinese family

<i>Gnas</i> Loss Causes Chondrocyte Fate Conversion in Cranial Suture Formation

Genetic and Epigenetic Characteristics of Autosomal Dominant Pseudohypoparathyroidism Type 1B: Case Reports and Literature Review

Evaluating the Variety of GNAS Inactivation Disorders and Their Clinical Manifestations in 11 Chinese Children

Resistance to the lipolytic action of epinephrine: a new feature of protein Gs deficiency